Comments
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on November 11, 2016, inter alia, to consider, the Unaudited Financial Results for the quarter and half year ended September 30, 2016, and related matters (Q2). Further note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 Trading Window for dealing in the securities of the Company will be closed from November 01, 2016 to November 13, 2016 (both days inclusive). Trading window will be opened from November 14, 2016.
Pdf Link:>Q2 results on Nov 11, 2016
Source : BSE - >www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.